UAE recalls some Nestle infant formula products, Qatar warns consumers

The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.

The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.

The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.

Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps. 

At least 37 countries, including most European states, as well as Australia, Brazil, China, Mexico and South Africa have issued health warnings over the infant formulas possibly being contaminated.

The recall piles more pressure on the KitKat and Nescafe maker and its new CEO, Philipp Navratil, who is seeking to revive growth through a portfolio review after management upheavals. Nestle shares are down about 5.7% so far this week.

Brazil's health ministry said on Wednesday that the Nestle recall was a preventative measure after the toxin had been detected in products originating in the Netherlands.

Nestle Australia said the batches recalled there had been manufactured in Switzerland, while Nestle China said it was recalling formula batches imported from Europe.

A notice from South Africa's National Consumer Commission said that the NAN infant formula being recalled was produced in June 2025 and has a lifespan of about 18 months.

"It was also exported to Namibia and Eswatini," the commission said.

Austria's health ministry said on Tuesday that the recall affected 800-plus products from more than 10 factories and was the largest in Nestle's history. A Nestle spokesperson could not verify this.

Nestle said on Tuesday that it had tested all arachidonic acid oil and corresponding oil mixes used in production of its potentially affected infant nutrition products after a quality issue was detected in an ingredient from a leading supplier.

It is now ramping up production and activating alternative suppliers of the acid oil to maintain supply.